Posterior cingulate neurometabolite profiles and clinical phenotype in frontotemporal dementia

Cognitive and Behavioral Neurology

Volumn 19, Issue 4, 2006, Pages 185-189

  Garrard, Peter ^a,b   Schott, Jonathan M ^b   MacManus, David G ^c   Hodges, John R ^d   Fox, Nicholas C ^c   Waldman, Adam D ^c,e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^e CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

Alzheimer disease; Frontotemporal lobar degeneration; MR spectroscopy; Progressive nonfluent aphasia; SD

Indexed keywords

N ACETYLASPARTIC ACID;

AGED; ALZHEIMER DISEASE; ARTICLE; ATAXIC APHASIA; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MALE; METABOLITE; PHENOTYPE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

AGED; ALZHEIMER DISEASE; ASPARTIC ACID; ATROPHY; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; FRONTAL LOBE; HUMANS; INOSITOL; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MATCHED-PAIR ANALYSIS; MIDDLE AGED; TEMPORAL LOBE;

EID: 33845759941     PISSN: 15433633     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wnn.0000213915.72395.77     Document Type: Article

References (24)

1. Hodges JR, Miller B. The classification, genetics and neuropathology of frontotemporal dementia. Introduction to the special topic papers: part I. Neurocase. 2001;7:31-35.
2. Gorno-Tempini ML, Dronkers NF, Rankin KP, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol. 2004;55:335-346.
3. Nestor PJ, Graham NL, Fryer TD, et al. Progressive non-fluent aphasia is associated with hypometabolism centred on the left anterior insula. Brain. 2003;126:2406-2418.
4. Rossor MN, Revesz T, Lantos PL, et al. Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. Brain. 2000;123:267-276.
5. Kertesz A, Munoz D. Clinical and pathological characteristics of primary progressive aphasia and frontal dementia 15. J Neural Transm. 1996;47:133-141.
6. Linn RT, Wolf PA, Bachman DL, et al. The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort 22. Arch Neurol. 1995;52:485-490.
7. Greene JD, Baddeley AD, Hodges JR. Analysis of the episodic memory deficit in early Alzheimer's disease: evidence from the doors and people test 5. Neuropsychologia. 1996;34:537-551.
8. Perry RJ, Watson P, Hodges JR. The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: relationship to episodic and semantic memory impairment 7. Neuropsychologia. 2000;38:252-271.
9. Lambon Ralph MA, Patterson K, Graham N, et al. Homogeneity and heterogeneity in mild cognitive impairment and Alzheimer's disease: a cross-sectional and longitudinal study of 55 cases. Brain. 2003;126:2350-2362.
10. Nestor PJ, Fryer TD, Ikeda M, et al. Retrosplenial cortex (BA 29/30) hypometabolism in mild cognitive impairment (prodromal Alzheimer's disease). Eur J Neurosci. 2003;18:2663-2667.
11. Scahill RI, Schott JM, Stevens JM, et al. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proc Natl Acad Sci. 2002;99:4703-4707.
12. Braak H, Braak E. Staging of Alzheimer's disease-related neuro-fibrillary changes. Neurobiol Aging. 1995;16:271-278.
13. Valenzuela MJ, Sachdev P. Magnetic resonance spectroscopy in AD. Neurology. 2001;56:592-598.
14. Kantarci K, Jack CR, Xu YC, et al. Regional metabolic patterns in mild cognitive impairment and Alzheimer's disease: a 1H MRS study. Neurology. 2000;55:210-217.
15. Schuff N, Amend DL, Meyerhoff DJ, et al. Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain. Radiology. 1998;207:91-102.
16. Schuff N, Capizzano AA, Du AT, et al. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology. 2002;58:928-935.
17. Ernst T, Chang L, Melchor R, et al. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology. 1997;203:829-836.
18. Kizu O, Yamada K, Nishimura T. Posterior cingulate metabolic changes in frontotemporal lobar degeneration detected by magnetic resonance spectroscopy. Neuroradiology. 2004;46:277-281.
19. Kantarci K, Petersen RC, Boeve BF, et al. 1H MR spectroscopy in common dementias. Neurology. 2004;63:1393-1398.
20. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546-1554.
21. Waldman AD, Rai GS. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study. Neuroradiology. 2003;45:507-512.
22. Kizu O, Yamada K, Nishimura T. Posterior cingulated metabolic changes in Frontotemporal lobar degeneration detected by magnetic resonance spectroscopy. Neuroradiology. 2004;46:277-281.
23. Graham NL, Bak TH, Patterson K, et al. Language function and dysfunction in corticobasal degeneration. Neurology. 2003;61:493-499.
24. Graham NL, Bak TH, Hodges JR. Corticobasal degeneration as a cognitive disorder. Mov Disord. 2003;18:1224-1232.